Greek Problems Continue

21 March 1997

Drug companies in Greece say their sales have fallen 20%-25% as a resultof recent curbs on prescribing, mainly by sickfund doctors (Marketletter March 24).

Also, the payment of hospital debts to suppliers agreed last month (Marketletter February 3) cannot yet be made, because the amounts the drug companies say they are owed are being questioned by hospital managers. Representatives of the manufacturers, importers and agents were due to seek a meeting with Health Minister Costas Gitonas over the matter.

The regulation being delayed says 5% of debt should be paid immediately in cash and the rest with government bonds. The debts concern invoices issued to November 30, 1996. Also, payments to suppliers should be made within three months of receipt of the invoice by the relevant hospital department, and no new order may be made if the hospital has not met its obligations within the three months.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight